Udayavni Special

Clinical trials indicate India’s vaccines will be effective against Covid-19 variants: ICMR

PTI, Feb 19, 2021, 12:14 PM IST

Source: Unsplash

Thiruvananthapuram: Indian Council of Medical Research (ICMR) Director-General Dr. Balram Bhargavahas said interim results of the ongoing clinical trials indicated that the indigenous Covid-19 vaccines would be effective against the mutated virus strains reported from theUnited Kingdom, South Africa, and Brazil.

A paper on Covaxin’s neutralization potential against the UK strain has been accepted for publication, he said here on Thursday while addressing an international webinar ”KeralaHealth: Making the SDG A Reality,” organized by the Department of Health and Family Welfare, Government of Kerala.

In the case of the variants from South Africa and Brazil, efforts were on to isolate the mutated virus strains from the samples collected from travelers from these two countries, he said.

The official said the third clinical trial of CovaxinBB152 had been completed as all the 25,800 volunteers involved in the exercise had been administered both doses.

”The interim analysis report should be out in a week,” he said.

Dr. Bhargava pointed out that India was the fifth country in the world to isolate the Covid-19 virus as part of the efforts to develop a vaccine for the pandemic.

With its graded response to the outbreak of Covid-19right from the beginning, India had successfully kept the spread of the pandemic under control while utilizing this period for drastically scaling up the capacity of the country’s medical infrastructure, both under the government and the private sector.

India had from the outset resisted the temptation of going for herd immunity unlike many European countries, including the UK and Italy, and its decision had been vindicated from what happened in the western nations that allowed the pandemic to spread, he pointed out.

As a result, India had not only ramped up its medical infrastructure for domestic use but had also reached the level of exporting vaccines and treatment kits on a large scale, he said.

The webinar series that began on February 17, with a focus on the prospects of achieving sustainable development goals (SDGs) amid an added challenge posed by Covid-19, is held across five days this month and early March.

Udayavani is now on Telegram. Click here to join our channel and stay updated with the latest news.

Top News

M’luru ComPol and DyCP chase truck smuggling sand on scooter

Chikmagalur: Cinematic chase of dacoits ensues by locals after failed robbery

Bellary: Man kills lawyer on court premises

South Korea allows workers to squeeze extra doses

Online impersonation case: Hrithik appears before police

India extends restrictions on international passenger flights till March 31

Maha board exams for Classes 12, 10 to begin on April 23, 29

Related Articles More

Protein inherited by humans from neanderthals linked to reduced COVID-19 severity: Study

Sr citizens, those over 45yrs with co-morbidities can now register to get COVID-19 vaccine

Tie-up with Serum Institute of India key to mass production of COVID vaccines, say two pharma majors

Professionals in India confident about career progress despite uncertainties: Survey

Side effects of eating too much McDonalds


Chikmagalur: Locals apprehend dacoits after cinematic chase

I request BJP senior leaders not to trust HD Kumaraswamy and BJP must not form an alliance with the JDS: C P Yogeshwar

Problem! in Cowin App

Listen to the story by Dr. Gururaj Karjagi on the concept of ‘Joy of Giving’- Part-3

This full-time construction worker makes caps from areca leaves in his spare time

Latest Additions

Priyanka offers prayers at Ravidas temple in Varanasi

Fuel price hike: Youth Congress stages protest outside residence of Smriti Irani

”BJP will take care of family of RSS worker killed in clash”

Hinduism and Hinudtva are different, says Yathindra Siddaramaiah

Comments against judges a disturbing new trend: Ravi Shankar Prasad

Thanks for visiting Udayavani

You seem to have an Ad Blocker on.
To continue reading, please turn it off or whitelist Udayavani.